393 related articles for article (PubMed ID: 20585067)
1. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
Ray KK; Seshasai SR; Erqou S; Sever P; Jukema JW; Ford I; Sattar N
Arch Intern Med; 2010 Jun; 170(12):1024-31. PubMed ID: 20585067
[TBL] [Abstract][Full Text] [Related]
2. Are statins effective in high-risk primary prevention?
Dentali F; Guasti L
Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
[No Abstract] [Full Text] [Related]
3. Statins and all-cause mortality in high-risk primary prevention: a second look at the results.
Chodick G; Shalev V
Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767
[No Abstract] [Full Text] [Related]
4. [Does statin therapy reduce the risk of stroke? A meta-analysis].
Sirol M; Bouzamondo A; Sanchez P; Lechat P
Ann Med Interne (Paris); 2001 Apr; 152(3):188-93. PubMed ID: 11431579
[TBL] [Abstract][Full Text] [Related]
5. [Primary and secondary prevention of coronary disease by statins].
Ferrières J
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
[TBL] [Abstract][Full Text] [Related]
6. Continuation of statin treatment and all-cause mortality: a population-based cohort study.
Shalev V; Chodick G; Silber H; Kokia E; Jan J; Heymann AD
Arch Intern Med; 2009 Feb; 169(3):260-8. PubMed ID: 19204217
[TBL] [Abstract][Full Text] [Related]
7. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
8. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
9. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
10. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis.
Petretta M; Costanzo P; Perrone-Filardi P; Chiariello M
Int J Cardiol; 2010 Jan; 138(1):25-31. PubMed ID: 18793814
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of statin therapy in adults with coronary heart disease.
Wilt TJ; Bloomfield HE; MacDonald R; Nelson D; Rutks I; Ho M; Larsen G; McCall A; Pineros S; Sales A
Arch Intern Med; 2004 Jul; 164(13):1427-36. PubMed ID: 15249352
[TBL] [Abstract][Full Text] [Related]
12. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
13. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.
Thavendiranathan P; Bagai A; Brookhart MA; Choudhry NK
Arch Intern Med; 2006 Nov; 166(21):2307-13. PubMed ID: 17130382
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Moyad MA; Merrick GS
Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
[TBL] [Abstract][Full Text] [Related]
15. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials.
Briel M; Studer M; Glass TR; Bucher HC
Am J Med; 2004 Oct; 117(8):596-606. PubMed ID: 15465509
[TBL] [Abstract][Full Text] [Related]
16. Statins and all-cause mortality in high-risk primary prevention of patients with cardiovascular risk factors.
Brugts JJ; Deckers JW
Arch Intern Med; 2010 Dec; 170(22):2041; author reply 2043-4. PubMed ID: 21149768
[No Abstract] [Full Text] [Related]
17. Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.
Afilalo J; Duque G; Steele R; Jukema JW; de Craen AJ; Eisenberg MJ
J Am Coll Cardiol; 2008 Jan; 51(1):37-45. PubMed ID: 18174034
[TBL] [Abstract][Full Text] [Related]
18. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
Zhou Z; Rahme E; Pilote L
Am Heart J; 2006 Feb; 151(2):273-81. PubMed ID: 16442888
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease.
Ferdinand KC
Curr Med Res Opin; 2005 Jul; 21(7):1091-7. PubMed ID: 16004678
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
Marchioli R; Marfisi RM; Carinci F; Tognoni G
Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
